A Patent Decision on Crispr Gene Editing Favors MIT
Feb 17, 2017•8 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The fight over who owns the most promising technique for editing genes-cutting and pasting the stuff of life to cure disease and advance scientific knowledge-has been a rough one. A team on the West Coast, at UC Berkeley, filed patents on the method, Crispr-Cas9; a team on the East Coast, based at MIT and the Broad Institute, filed their own patents in 2014 after Berkeley's, but got them granted first.
Learn about your ad choices: dovetail.prx.org/ad-choices
For the best experience, listen in Metacast app for iOS or Android